Global Targeted Chemotherapy Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
The global Targeted Chemotherapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Chemotherapy Drugs Industry Forecast” looks at past sales and reviews total world Targeted Chemotherapy Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Targeted Chemotherapy Drugs sales for 2024 through 2030. With Targeted Chemotherapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Chemotherapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeted Chemotherapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Chemotherapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Chemotherapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Chemotherapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Chemotherapy Drugs.
United States market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Chemotherapy Drugs players cover Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Chemotherapy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Targeted Chemotherapy Drugs market?
What factors are driving Targeted Chemotherapy Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Chemotherapy Drugs market opportunities vary by end market size?
How does Targeted Chemotherapy Drugs break out by Type, by Application?
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
The global Targeted Chemotherapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Chemotherapy Drugs Industry Forecast” looks at past sales and reviews total world Targeted Chemotherapy Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Targeted Chemotherapy Drugs sales for 2024 through 2030. With Targeted Chemotherapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Chemotherapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeted Chemotherapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Chemotherapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Chemotherapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Chemotherapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Chemotherapy Drugs.
United States market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Chemotherapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Chemotherapy Drugs players cover Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Chemotherapy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies (MABs)
- Cancer Growth Blockers
- Angiogenesis Inhibitors
- PARP Inhibitors
- Breast Cancer Treatment
- Lung Cancer Treatment
- Gastric Cancer Treatment
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Celgene
- Bristol-Myers Squibb
- Takeda
- Seekyo
What is the 10-year outlook for the global Targeted Chemotherapy Drugs market?
What factors are driving Targeted Chemotherapy Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Chemotherapy Drugs market opportunities vary by end market size?
How does Targeted Chemotherapy Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Chemotherapy Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Targeted Chemotherapy Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Targeted Chemotherapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Targeted Chemotherapy Drugs Segment by Type
2.2.1 Monoclonal Antibodies (MABs)
2.2.2 Cancer Growth Blockers
2.2.3 Angiogenesis Inhibitors
2.2.4 PARP Inhibitors
2.3 Targeted Chemotherapy Drugs Sales by Type
2.3.1 Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Targeted Chemotherapy Drugs Sale Price by Type (2019-2024)
2.4 Targeted Chemotherapy Drugs Segment by Application
2.4.1 Breast Cancer Treatment
2.4.2 Lung Cancer Treatment
2.4.3 Gastric Cancer Treatment
2.4.4 Others
2.5 Targeted Chemotherapy Drugs Sales by Application
2.5.1 Global Targeted Chemotherapy Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Targeted Chemotherapy Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Targeted Chemotherapy Drugs Breakdown Data by Company
3.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Targeted Chemotherapy Drugs Sales Market Share by Company (2019-2024)
3.2 Global Targeted Chemotherapy Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Targeted Chemotherapy Drugs Revenue by Company (2019-2024)
3.2.2 Global Targeted Chemotherapy Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Targeted Chemotherapy Drugs Sale Price by Company
3.4 Key Manufacturers Targeted Chemotherapy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Chemotherapy Drugs Product Location Distribution
3.4.2 Players Targeted Chemotherapy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETED CHEMOTHERAPY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Chemotherapy Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Targeted Chemotherapy Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Targeted Chemotherapy Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Targeted Chemotherapy Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Targeted Chemotherapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Chemotherapy Drugs Sales Growth
4.4 APAC Targeted Chemotherapy Drugs Sales Growth
4.5 Europe Targeted Chemotherapy Drugs Sales Growth
4.6 Middle East & Africa Targeted Chemotherapy Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeted Chemotherapy Drugs Sales by Country
5.1.1 Americas Targeted Chemotherapy Drugs Sales by Country (2019-2024)
5.1.2 Americas Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
5.2 Americas Targeted Chemotherapy Drugs Sales by Type (2019-2024)
5.3 Americas Targeted Chemotherapy Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Chemotherapy Drugs Sales by Region
6.1.1 APAC Targeted Chemotherapy Drugs Sales by Region (2019-2024)
6.1.2 APAC Targeted Chemotherapy Drugs Revenue by Region (2019-2024)
6.2 APAC Targeted Chemotherapy Drugs Sales by Type (2019-2024)
6.3 APAC Targeted Chemotherapy Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Chemotherapy Drugs by Country
7.1.1 Europe Targeted Chemotherapy Drugs Sales by Country (2019-2024)
7.1.2 Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
7.2 Europe Targeted Chemotherapy Drugs Sales by Type (2019-2024)
7.3 Europe Targeted Chemotherapy Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Chemotherapy Drugs by Country
8.1.1 Middle East & Africa Targeted Chemotherapy Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Targeted Chemotherapy Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Targeted Chemotherapy Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Chemotherapy Drugs
10.3 Manufacturing Process Analysis of Targeted Chemotherapy Drugs
10.4 Industry Chain Structure of Targeted Chemotherapy Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Chemotherapy Drugs Distributors
11.3 Targeted Chemotherapy Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETED CHEMOTHERAPY DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeted Chemotherapy Drugs Market Size Forecast by Region
12.1.1 Global Targeted Chemotherapy Drugs Forecast by Region (2025-2030)
12.1.2 Global Targeted Chemotherapy Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Targeted Chemotherapy Drugs Forecast by Type (2025-2030)
12.7 Global Targeted Chemotherapy Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.1.3 Roche Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.2.3 Celgene Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Information
13.3.2 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bristol-Myers Squibb Main Business Overview
13.3.5 Bristol-Myers Squibb Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.4.3 Takeda Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Seekyo
13.5.1 Seekyo Company Information
13.5.2 Seekyo Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.5.3 Seekyo Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Seekyo Main Business Overview
13.5.5 Seekyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Chemotherapy Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Targeted Chemotherapy Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Targeted Chemotherapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Targeted Chemotherapy Drugs Segment by Type
2.2.1 Monoclonal Antibodies (MABs)
2.2.2 Cancer Growth Blockers
2.2.3 Angiogenesis Inhibitors
2.2.4 PARP Inhibitors
2.3 Targeted Chemotherapy Drugs Sales by Type
2.3.1 Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Targeted Chemotherapy Drugs Sale Price by Type (2019-2024)
2.4 Targeted Chemotherapy Drugs Segment by Application
2.4.1 Breast Cancer Treatment
2.4.2 Lung Cancer Treatment
2.4.3 Gastric Cancer Treatment
2.4.4 Others
2.5 Targeted Chemotherapy Drugs Sales by Application
2.5.1 Global Targeted Chemotherapy Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Targeted Chemotherapy Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Targeted Chemotherapy Drugs Breakdown Data by Company
3.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Targeted Chemotherapy Drugs Sales Market Share by Company (2019-2024)
3.2 Global Targeted Chemotherapy Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Targeted Chemotherapy Drugs Revenue by Company (2019-2024)
3.2.2 Global Targeted Chemotherapy Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Targeted Chemotherapy Drugs Sale Price by Company
3.4 Key Manufacturers Targeted Chemotherapy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Chemotherapy Drugs Product Location Distribution
3.4.2 Players Targeted Chemotherapy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETED CHEMOTHERAPY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Chemotherapy Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Targeted Chemotherapy Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Targeted Chemotherapy Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Targeted Chemotherapy Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Targeted Chemotherapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Chemotherapy Drugs Sales Growth
4.4 APAC Targeted Chemotherapy Drugs Sales Growth
4.5 Europe Targeted Chemotherapy Drugs Sales Growth
4.6 Middle East & Africa Targeted Chemotherapy Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeted Chemotherapy Drugs Sales by Country
5.1.1 Americas Targeted Chemotherapy Drugs Sales by Country (2019-2024)
5.1.2 Americas Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
5.2 Americas Targeted Chemotherapy Drugs Sales by Type (2019-2024)
5.3 Americas Targeted Chemotherapy Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Chemotherapy Drugs Sales by Region
6.1.1 APAC Targeted Chemotherapy Drugs Sales by Region (2019-2024)
6.1.2 APAC Targeted Chemotherapy Drugs Revenue by Region (2019-2024)
6.2 APAC Targeted Chemotherapy Drugs Sales by Type (2019-2024)
6.3 APAC Targeted Chemotherapy Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Chemotherapy Drugs by Country
7.1.1 Europe Targeted Chemotherapy Drugs Sales by Country (2019-2024)
7.1.2 Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
7.2 Europe Targeted Chemotherapy Drugs Sales by Type (2019-2024)
7.3 Europe Targeted Chemotherapy Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Chemotherapy Drugs by Country
8.1.1 Middle East & Africa Targeted Chemotherapy Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Targeted Chemotherapy Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Targeted Chemotherapy Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Targeted Chemotherapy Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Chemotherapy Drugs
10.3 Manufacturing Process Analysis of Targeted Chemotherapy Drugs
10.4 Industry Chain Structure of Targeted Chemotherapy Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Chemotherapy Drugs Distributors
11.3 Targeted Chemotherapy Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETED CHEMOTHERAPY DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeted Chemotherapy Drugs Market Size Forecast by Region
12.1.1 Global Targeted Chemotherapy Drugs Forecast by Region (2025-2030)
12.1.2 Global Targeted Chemotherapy Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Targeted Chemotherapy Drugs Forecast by Type (2025-2030)
12.7 Global Targeted Chemotherapy Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.1.3 Roche Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.2.3 Celgene Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Information
13.3.2 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bristol-Myers Squibb Main Business Overview
13.3.5 Bristol-Myers Squibb Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.4.3 Takeda Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Seekyo
13.5.1 Seekyo Company Information
13.5.2 Seekyo Targeted Chemotherapy Drugs Product Portfolios and Specifications
13.5.3 Seekyo Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Seekyo Main Business Overview
13.5.5 Seekyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Chemotherapy Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Targeted Chemotherapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (MABs)
Table 4. Major Players of Cancer Growth Blockers
Table 5. Major Players of Angiogenesis Inhibitors
Table 6. Major Players of PARP Inhibitors
Table 7. Global Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Table 9. Global Targeted Chemotherapy Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global Targeted Chemotherapy Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Targeted Chemotherapy Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global Targeted Chemotherapy Drugs Sale Market Share by Application (2019-2024)
Table 14. Global Targeted Chemotherapy Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global Targeted Chemotherapy Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Targeted Chemotherapy Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global Targeted Chemotherapy Drugs Sales Market Share by Company (2019-2024)
Table 19. Global Targeted Chemotherapy Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global Targeted Chemotherapy Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global Targeted Chemotherapy Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Targeted Chemotherapy Drugs Producing Area Distribution and Sales Area
Table 23. Players Targeted Chemotherapy Drugs Products Offered
Table 24. Targeted Chemotherapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Targeted Chemotherapy Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Targeted Chemotherapy Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global Targeted Chemotherapy Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Targeted Chemotherapy Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Targeted Chemotherapy Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global Targeted Chemotherapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Targeted Chemotherapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 39. Americas Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC Targeted Chemotherapy Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC Targeted Chemotherapy Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC Targeted Chemotherapy Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 44. APAC Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 48. Europe Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Targeted Chemotherapy Drugs
Table 54. Key Market Challenges & Risks of Targeted Chemotherapy Drugs
Table 55. Key Industry Trends of Targeted Chemotherapy Drugs
Table 56. Targeted Chemotherapy Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Targeted Chemotherapy Drugs Distributors List
Table 59. Targeted Chemotherapy Drugs Customer List
Table 60. Global Targeted Chemotherapy Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global Targeted Chemotherapy Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas Targeted Chemotherapy Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC Targeted Chemotherapy Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC Targeted Chemotherapy Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe Targeted Chemotherapy Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa Targeted Chemotherapy Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global Targeted Chemotherapy Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global Targeted Chemotherapy Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global Targeted Chemotherapy Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global Targeted Chemotherapy Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Roche Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 76. Roche Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Celgene Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Celgene Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 81. Celgene Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Celgene Main Business
Table 83. Celgene Latest Developments
Table 84. Bristol-Myers Squibb Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 86. Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Bristol-Myers Squibb Main Business
Table 88. Bristol-Myers Squibb Latest Developments
Table 89. Takeda Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Takeda Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 91. Takeda Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Takeda Main Business
Table 93. Takeda Latest Developments
Table 94. Seekyo Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Seekyo Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 96. Seekyo Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Seekyo Main Business
Table 98. Seekyo Latest Developments
Table 1. Targeted Chemotherapy Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Targeted Chemotherapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (MABs)
Table 4. Major Players of Cancer Growth Blockers
Table 5. Major Players of Angiogenesis Inhibitors
Table 6. Major Players of PARP Inhibitors
Table 7. Global Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Table 9. Global Targeted Chemotherapy Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global Targeted Chemotherapy Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Targeted Chemotherapy Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global Targeted Chemotherapy Drugs Sale Market Share by Application (2019-2024)
Table 14. Global Targeted Chemotherapy Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global Targeted Chemotherapy Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Targeted Chemotherapy Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global Targeted Chemotherapy Drugs Sales Market Share by Company (2019-2024)
Table 19. Global Targeted Chemotherapy Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global Targeted Chemotherapy Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global Targeted Chemotherapy Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Targeted Chemotherapy Drugs Producing Area Distribution and Sales Area
Table 23. Players Targeted Chemotherapy Drugs Products Offered
Table 24. Targeted Chemotherapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Targeted Chemotherapy Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Targeted Chemotherapy Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global Targeted Chemotherapy Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Targeted Chemotherapy Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Targeted Chemotherapy Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global Targeted Chemotherapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Targeted Chemotherapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 39. Americas Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC Targeted Chemotherapy Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC Targeted Chemotherapy Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC Targeted Chemotherapy Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 44. APAC Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 48. Europe Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa Targeted Chemotherapy Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa Targeted Chemotherapy Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Targeted Chemotherapy Drugs
Table 54. Key Market Challenges & Risks of Targeted Chemotherapy Drugs
Table 55. Key Industry Trends of Targeted Chemotherapy Drugs
Table 56. Targeted Chemotherapy Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Targeted Chemotherapy Drugs Distributors List
Table 59. Targeted Chemotherapy Drugs Customer List
Table 60. Global Targeted Chemotherapy Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global Targeted Chemotherapy Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas Targeted Chemotherapy Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC Targeted Chemotherapy Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC Targeted Chemotherapy Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe Targeted Chemotherapy Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa Targeted Chemotherapy Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa Targeted Chemotherapy Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global Targeted Chemotherapy Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global Targeted Chemotherapy Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global Targeted Chemotherapy Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global Targeted Chemotherapy Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Roche Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 76. Roche Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Celgene Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Celgene Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 81. Celgene Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Celgene Main Business
Table 83. Celgene Latest Developments
Table 84. Bristol-Myers Squibb Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 86. Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Bristol-Myers Squibb Main Business
Table 88. Bristol-Myers Squibb Latest Developments
Table 89. Takeda Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Takeda Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 91. Takeda Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Takeda Main Business
Table 93. Takeda Latest Developments
Table 94. Seekyo Basic Information, Targeted Chemotherapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Seekyo Targeted Chemotherapy Drugs Product Portfolios and Specifications
Table 96. Seekyo Targeted Chemotherapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Seekyo Main Business
Table 98. Seekyo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Targeted Chemotherapy Drugs
Figure 2. Targeted Chemotherapy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Chemotherapy Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Targeted Chemotherapy Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Targeted Chemotherapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2023)
Figure 10. Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monoclonal Antibodies (MABs)
Figure 12. Product Picture of Cancer Growth Blockers
Figure 13. Product Picture of Angiogenesis Inhibitors
Figure 14. Product Picture of PARP Inhibitors
Figure 15. Global Targeted Chemotherapy Drugs Sales Market Share by Type in 2023
Figure 16. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2024)
Figure 17. Targeted Chemotherapy Drugs Consumed in Breast Cancer Treatment
Figure 18. Global Targeted Chemotherapy Drugs Market: Breast Cancer Treatment (2019-2024) & (K Units)
Figure 19. Targeted Chemotherapy Drugs Consumed in Lung Cancer Treatment
Figure 20. Global Targeted Chemotherapy Drugs Market: Lung Cancer Treatment (2019-2024) & (K Units)
Figure 21. Targeted Chemotherapy Drugs Consumed in Gastric Cancer Treatment
Figure 22. Global Targeted Chemotherapy Drugs Market: Gastric Cancer Treatment (2019-2024) & (K Units)
Figure 23. Targeted Chemotherapy Drugs Consumed in Others
Figure 24. Global Targeted Chemotherapy Drugs Market: Others (2019-2024) & (K Units)
Figure 25. Global Targeted Chemotherapy Drugs Sale Market Share by Application (2023)
Figure 26. Global Targeted Chemotherapy Drugs Revenue Market Share by Application in 2023
Figure 27. Targeted Chemotherapy Drugs Sales by Company in 2023 (K Units)
Figure 28. Global Targeted Chemotherapy Drugs Sales Market Share by Company in 2023
Figure 29. Targeted Chemotherapy Drugs Revenue by Company in 2023 ($ millions)
Figure 30. Global Targeted Chemotherapy Drugs Revenue Market Share by Company in 2023
Figure 31. Global Targeted Chemotherapy Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Targeted Chemotherapy Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 34. Americas Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 35. APAC Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 36. APAC Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 37. Europe Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 38. Europe Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 41. Americas Targeted Chemotherapy Drugs Sales Market Share by Country in 2023
Figure 42. Americas Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Figure 43. Americas Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 44. Americas Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Targeted Chemotherapy Drugs Sales Market Share by Region in 2023
Figure 50. APAC Targeted Chemotherapy Drugs Revenue Market Share by Region (2019-2024)
Figure 51. APAC Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 52. APAC Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 53. China Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. India Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. China Taiwan Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Targeted Chemotherapy Drugs Sales Market Share by Country in 2023
Figure 61. Europe Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Figure 62. Europe Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 63. Europe Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. France Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 72. Egypt Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. Turkey Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Targeted Chemotherapy Drugs in 2023
Figure 78. Manufacturing Process Analysis of Targeted Chemotherapy Drugs
Figure 79. Industry Chain Structure of Targeted Chemotherapy Drugs
Figure 80. Channels of Distribution
Figure 81. Global Targeted Chemotherapy Drugs Sales Market Forecast by Region (2025-2030)
Figure 82. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Targeted Chemotherapy Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Targeted Chemotherapy Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Targeted Chemotherapy Drugs
Figure 2. Targeted Chemotherapy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Chemotherapy Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Targeted Chemotherapy Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Targeted Chemotherapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2023)
Figure 10. Targeted Chemotherapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monoclonal Antibodies (MABs)
Figure 12. Product Picture of Cancer Growth Blockers
Figure 13. Product Picture of Angiogenesis Inhibitors
Figure 14. Product Picture of PARP Inhibitors
Figure 15. Global Targeted Chemotherapy Drugs Sales Market Share by Type in 2023
Figure 16. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2024)
Figure 17. Targeted Chemotherapy Drugs Consumed in Breast Cancer Treatment
Figure 18. Global Targeted Chemotherapy Drugs Market: Breast Cancer Treatment (2019-2024) & (K Units)
Figure 19. Targeted Chemotherapy Drugs Consumed in Lung Cancer Treatment
Figure 20. Global Targeted Chemotherapy Drugs Market: Lung Cancer Treatment (2019-2024) & (K Units)
Figure 21. Targeted Chemotherapy Drugs Consumed in Gastric Cancer Treatment
Figure 22. Global Targeted Chemotherapy Drugs Market: Gastric Cancer Treatment (2019-2024) & (K Units)
Figure 23. Targeted Chemotherapy Drugs Consumed in Others
Figure 24. Global Targeted Chemotherapy Drugs Market: Others (2019-2024) & (K Units)
Figure 25. Global Targeted Chemotherapy Drugs Sale Market Share by Application (2023)
Figure 26. Global Targeted Chemotherapy Drugs Revenue Market Share by Application in 2023
Figure 27. Targeted Chemotherapy Drugs Sales by Company in 2023 (K Units)
Figure 28. Global Targeted Chemotherapy Drugs Sales Market Share by Company in 2023
Figure 29. Targeted Chemotherapy Drugs Revenue by Company in 2023 ($ millions)
Figure 30. Global Targeted Chemotherapy Drugs Revenue Market Share by Company in 2023
Figure 31. Global Targeted Chemotherapy Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Targeted Chemotherapy Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 34. Americas Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 35. APAC Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 36. APAC Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 37. Europe Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 38. Europe Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Targeted Chemotherapy Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Targeted Chemotherapy Drugs Revenue 2019-2024 ($ millions)
Figure 41. Americas Targeted Chemotherapy Drugs Sales Market Share by Country in 2023
Figure 42. Americas Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Figure 43. Americas Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 44. Americas Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Targeted Chemotherapy Drugs Sales Market Share by Region in 2023
Figure 50. APAC Targeted Chemotherapy Drugs Revenue Market Share by Region (2019-2024)
Figure 51. APAC Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 52. APAC Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 53. China Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. India Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. China Taiwan Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Targeted Chemotherapy Drugs Sales Market Share by Country in 2023
Figure 61. Europe Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Figure 62. Europe Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 63. Europe Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. France Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Figure 72. Egypt Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. Turkey Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Targeted Chemotherapy Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Targeted Chemotherapy Drugs in 2023
Figure 78. Manufacturing Process Analysis of Targeted Chemotherapy Drugs
Figure 79. Industry Chain Structure of Targeted Chemotherapy Drugs
Figure 80. Channels of Distribution
Figure 81. Global Targeted Chemotherapy Drugs Sales Market Forecast by Region (2025-2030)
Figure 82. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Targeted Chemotherapy Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Targeted Chemotherapy Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Targeted Chemotherapy Drugs Revenue Market Share Forecast by Application (2025-2030)
